Item Type | Name |
Academic Article
|
On predictors of sudden cardiac death in hypertrophic cardiomyopathy.
|
Academic Article
|
Can an energy-deficient heart grow bigger and stronger?
|
Academic Article
|
Resolution of established cardiac hypertrophy and fibrosis and prevention of systolic dysfunction in a transgenic rabbit model of human cardiomyopathy through thiol-sensitive mechanisms.
|
Academic Article
|
Genetic fate mapping identifies second heart field progenitor cells as a source of adipocytes in arrhythmogenic right ventricular cardiomyopathy.
|
Academic Article
|
Update on hypertrophic cardiomyopathy.
|
Academic Article
|
Myozenin 2 is a novel gene for human hypertrophic cardiomyopathy.
|
Academic Article
|
Genome-wide mapping of modifier chromosomal loci for human hypertrophic cardiomyopathy.
|
Academic Article
|
Enhanced transmural fiber rotation and connexin 43 heterogeneity are associated with an increased upper limit of vulnerability in a transgenic rabbit model of human hypertrophic cardiomyopathy.
|
Academic Article
|
Differential interactions of thin filament proteins in two cardiac troponin T mouse models of hypertrophic and dilated cardiomyopathies.
|
Academic Article
|
Contemporary treatment of hypertrophic cardiomyopathy.
|
Academic Article
|
Arrhythmogenic right ventricular cardiomyopathy is a disease of cardiac stem cells.
|
Academic Article
|
Metabolomic distinction and insights into the pathogenesis of human primary dilated cardiomyopathy.
|
Academic Article
|
Hypertrophic cardiomyopathy: from genetics to treatment.
|
Academic Article
|
Experimental therapies in hypertrophic cardiomyopathy.
|
Academic Article
|
Atorvastatin and cardiac hypertrophy and function in hypertrophic cardiomyopathy: a pilot study.
|
Academic Article
|
Human molecular genetic and functional studies identify TRIM63, encoding Muscle RING Finger Protein 1, as a novel gene for human hypertrophic cardiomyopathy.
|
Academic Article
|
Pathogenesis of hypertrophic cardiomyopathy caused by myozenin 2 mutations is independent of calcineurin activity.
|
Academic Article
|
Antifibrotic effects of antioxidant N-acetylcysteine in a mouse model of human hypertrophic cardiomyopathy mutation.
|
Academic Article
|
Suppression of canonical Wnt/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy.
|
Academic Article
|
Phenotypic plasticity of sarcomeric protein mutations.
|
Academic Article
|
Molecular genetic and functional characterization implicate muscle-restricted coiled-coil gene (MURC) as a causal gene for familial dilated cardiomyopathy.
|
Concept
|
Cardiomyopathy, Hypertrophic
|
Concept
|
Cardiomyopathy, Restrictive
|
Concept
|
Cardiomyopathies
|
Concept
|
Cardiomyopathy, Dilated
|
Academic Article
|
On the diagnostic utility of junction plakoglobin in arrhythmogenic right ventricular cardiomyopathy.
|
Academic Article
|
Causality in genetics: the gradient of genetic effects and back to Koch's postulates of causality.
|
Academic Article
|
Ali J. Marian: life and science are one.
|
Academic Article
|
Arrhythmogenic cardiomyopathy in a patient with a rare loss-of-function KCNQ1 mutation.
|
Academic Article
|
Cardiac Fibro-Adipocyte Progenitors Express Desmosome Proteins and Preferentially Differentiate to Adipocytes Upon Deletion of the Desmoplakin Gene.
|
Academic Article
|
Challenges in the Diagnosis of Anderson-Fabry Disease: A Deceptively Simple and Yet Complicated Genetic Disease.
|
Academic Article
|
Genetics and Genomics of Single-Gene Cardiovascular Diseases: Common Hereditary Cardiomyopathies as Prototypes of?Single-Gene Disorders.
|
Academic Article
|
A Potential Oligogenic Etiology of Hypertrophic Cardiomyopathy: A Classic Single-Gene Disorder.
|
Academic Article
|
Identification of established arrhythmogenic right ventricular cardiomyopathy mutation in a patient with the contrasting phenotype of hypertrophic cardiomyopathy.
|
Academic Article
|
Hypertrophy Regression With N-Acetylcysteine in Hypertrophic Cardiomyopathy (HALT-HCM): A Randomized, Placebo-Controlled, Double-Blind Pilot Study.
|
Academic Article
|
Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy.
|
Academic Article
|
Distinct Cellular Basis for Early Cardiac Arrhythmias, the Cardinal Manifestation of Arrhythmogenic Cardiomyopathy, and the Skin Phenotype of Cardiocutaneous Syndromes.
|
Academic Article
|
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes Is Associated With Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy.
|
Academic Article
|
DNA Damage Response/TP53 Pathway Is Activated and Contributes to the Pathogenesis of Dilated Cardiomyopathy Associated With LMNA (Lamin A/C) Mutations.
|
Grant
|
Hypertrophy Regression with N-Acetylcysteine in Hypertrophic Cardiomyopathy
|
Grant
|
Cardiovascular Ultrasonography Unit
|
Grant
|
Canonical Wnt Signaling in Pathogenesis and Rescue of ARVC
|
Grant
|
Mechanisms and Therapeutic Targeting of DNA Damage in Dilated Cardiomyopathy Caused by LMNA Mutations
|
Grant
|
Modifier Genes of Familial Hypertrophic Cardiomyopathy
|
Academic Article
|
Exercise restores dysregulated gene expression in a mouse model of arrhythmogenic cardiomyopathy.
|
Academic Article
|
Role of the Extracellular Matrix in?the?Pathogenesis of Hypertrophic?Cardiomyopathy.
|
Academic Article
|
RNA sequencing-based transcriptome profiling of cardiac tissue implicates novel putative disease mechanisms in FLNC-associated arrhythmogenic cardiomyopathy.
|
Grant
|
Cell type-Specific Therapeutic Targeting of canonical WNT Pathway in Arrhythmogenic Cardiomyopathy
|
Academic Article
|
Genetic basis and molecular biology of cardiac arrhythmias in cardiomyopathies.
|
Academic Article
|
Evaluation of Mavacamten in Symptomatic Patients With Nonobstructive Hypertrophic Cardiomyopathy.
|
Academic Article
|
BET bromodomain inhibition attenuates cardiac phenotype in myocyte-specific lamin A/C-deficient mice.
|
Academic Article
|
Haploinsufficiency of Tmem43 in cardiac myocytes activates the DNA damage response pathway leading to a late-onset senescence-associated pro-fibrotic cardiomyopathy.
|
Academic Article
|
Single-Cell RNA Sequencing Uncovers Paracrine Functions of the Epicardial-Derived Cells in Arrhythmogenic Cardiomyopathy.
|
Academic Article
|
The EP300/TP53 pathway, a suppressor of the Hippo and canonical WNT pathways, is activated in human hearts with arrhythmogenic cardiomyopathy in the absence of overt heart failure.
|
Academic Article
|
Deletion of the Lmna gene in fibroblasts causes senescence-associated dilated cardiomyopathy by activating the double-stranded DNA damage response and induction of senescence-associated secretory phenotype.
|
Academic Article
|
Genetic Ablation of the DNA Damage Response Pathway Attenuates Lamin-Associated Dilated Cardiomyopathy in Mice.
|
Academic Article
|
Sporadic dilated cardiomyopathy is often familial.
|
Academic Article
|
A combinatorial oligogenic basis for the phenotypic plasticity between late-onset dilated and arrhythmogenic cardiomyopathy in a single family.
|
Academic Article
|
PANoptosis is a prominent feature of desmoplakin cardiomyopathy.
|
Academic Article
|
Pharmacological suppression of the WNT signaling pathway attenuates age-dependent expression of the phenotype in a mouse model of arrhythmogenic cardiomyopathy.
|
Academic Article
|
Clinical Significance of Variants in the TTN Gene in a Large Cohort of Patients With Sporadic Dilated Cardiomyopathy.
|
Academic Article
|
Oligogenic cardiomyopathy.
|
Academic Article
|
Shared Genetic Etiology of Primary Dilated Cardiomyopathy and Ischemic Dilated Cardiomyopathy.
|
Academic Article
|
Cytosolic DNA sensing protein pathway is activated in human hearts with dilated cardiomyopathy.
|
Academic Article
|
Genetic inactivation of ?-catenin is salubrious, whereas its activation is deleterious in desmoplakin cardiomyopathy.
|
Academic Article
|
A human mitofusin 2 mutation can cause mitophagic cardiomyopathy.
|
Academic Article
|
DNA double-stranded breaks, a hallmark of aging, defined at the nucleotide resolution, are increased and associated with transcription in the cardiac myocytes in LMNA-cardiomyopathy.
|